Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 3Venous Thrombosis 2Venous Thromboembolism 2Thrombosis 1Pulmonary Embolism 1Hemorrhage 1

Interventions

Dalteparin 5apixaban 4abelacimab 2MAA868 2isoquercitrin 1edoxaban 1bemiparin 1Tinzaparin 1Heparin, Low-Molecular-Weight 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pulmonary Embolism × bemiparin × Clear all
NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡